DSIJ Mindshare

Lupin Limited has announced that it has entered into a definitive distribution agreement with Aptissen S.A. Under this agreement, Aptissen has granted Lupin with the exclusive rights to market, distribute and sell the current Aptissen products in Canada.

Glenmark Pharmaceuticals announced positive results from a Phase 3 study of Ryaltris, an investigational fixed-dose combination nasal spray for the treatment of seasonal allergic rhinitis(SAR). 

Adani Group is said to be negotiating an approximately Rs. 1,500 crore deal with Kalpataru Power Transmission Limited (KPTL) for four of its transmission lines.

Overall volumes in futures & options currently stand at 1.98 crore contracts with a turnover of Rs. 13,24,483.37 crore.

Overall volumes in futures & options currently stand at 1.98 crore contracts with a turnover of Rs. 13,24,483.37 crore.